Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citation
Cited by
Items 401–497 of 497
Rios, W. Q., Silva, C. M., Ferreira, R. M., & Gomes, J. R. B. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02694-6 · Cited by 3
“This modification occurs in response to insulin signaling and reduces PGC-1α occupancy of promoter regions, leading to decreased expression of PCK1, G6PC, and MCAD [ 28].”
Gao, K., Zhang, W., Zhao, M., Xu, D. W., Tao, X., Li, W., Liu, M., Guo, C., Lu, Y., & Wang, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120737 · Cited by 5
Venkataraman, B., Jayaraman, S., Sathish, S., Mayilvanan, C., & Balasubramanian, K. (2012) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587212460047 · Cited by 4
Zhao, L., Zheng, Q., Zou, Y., Wang, Y., Wu, Y., & Liu, X. (2019) · Starch - Stärke · doi:10.1002/star.201900203 · Cited by 3
Insulin and the Physiology of Carbohydrate Metabolism
Pereira, S., & Giacca, A. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_1 · Cited by 4
The Role and Regulation of PGC-1α and PGC-1β in Skeletal Muscle Adaptation
Lamon, S., & Russell, A. P. (2017) · Springer eBooks · doi:10.1007/978-981-10-3292-9_8 · Cited by 4
Elfihry, R., Elmessaoudi-Idrissi, M., Jadid, F., Zaidane, I., Chihab, H., Tahiri, M., Kabine, M., Badre, W., Chemin, I., Marchio, A., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00220-7 · Cited by 3
Cheimonidi, C., Grivas, I. N., Sesti, F., Kavrochorianou, N., Gianniou, D. D., Taoufik, E., Badounas, F., Papassideri, I. S., Rizzi, F., Tsitsilonis, O., et al. (2021) · Aging · doi:10.18632/aging.202788 · Cited by 4
“Elevated GLU levels upregulate the metabolic genes akt, foxo1, pgc-1, g6pc and pepck in the liver, where activation of the phosphoinositol 3-kinase/AKT pathway inhibits the rate-controlling enzymes of gluconeogenesis and promotes glycogen synthesis [23, 24].”
BackgroundNicholas, L. M., & McMillen, I. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6386-7_7 · Cited by 4
Skeletal Muscle Mitochondrial Function/Dysfunction and Type 2 Diabetes
González-Franquesa, A., De, V., Lerín, C., & Pablo, M. (2012) · InTech eBooks · doi:10.5772/50130 · Cited by 4
Johnson-Gonzalez, C. B., Bowman-Gibson, S., Chandiramani, C. H., Linkous, B., Nolan, K., Stone, E. K., Wilcher, K. E., Bhakta-Yadav, M. S., Maxwell, R. A., Dhanraj, D. N., et al. (2026) · Placenta · doi:10.1016/j.placenta.2026.03.020 · Cited by 2
Hyatt, J. K., Lu, E. J., & McCall, G. E. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1420276 · Cited by 3
“The inactivation of PGC-1 α at this site has been directly attributed to the control of gluconeogenesis and/or fatty acid oxidation via Akt (Li et al., 2007).”
BackgroundRole of PGC-1α in the proliferation and metastasis of malignant tumors
Zhang, T., Zhao, S., & Gu, C. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10360-3 · Cited by 3
“The maintenance of PGC-1α activ - ity can also be achieved by inhibiting phosphatidylinositol 3-kinase/protein kinase B (AKT)-mediated phosphorylation and SUMOylation of PGC-1α (Li et al. 2007).”
Insulin Resistance and Its Biochemical Basis in Metabolic Syndrome
Hasnani, D., Iglesias-Fortes, S., Lockwood, Á. C., & Chavda, V. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_2 · Cited by 3
Tronko, M. D., Kovzun, О. I., Левчук, Н. І., PUSHKAREV, V. V., Lukashenia, O. S., & Pushkarev, V. M. (2023) · Endokrynologia · doi:10.31793/1680-1466.2023.28-1.5 · Cited by 2
Mitochondrial biogenesis and mitophagy
Tan, S., Kennedy, B. K., & Wong, E. S. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821562-3.00037-x · Cited by 2
Zhang, Y. (2012) · Scholarship@Western (Western University) · Cited by 2
Small molecule kaempferol, a novel regulator of glucose homeostasis in diabetes
Moore, W. T. (2017) · VTechWorks (Virginia Tech) · Cited by 4
Botezelli, J. D., Overby, P., Lindo, L., Wang, S., Haïda, O., Lim, G. E., Templeman, N. M., Pauli, J. R., & Johnson, J. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.31.018432 · Cited by 3
“Other studies have found that insulin signaling downregulates mitochondrial oxidative phosphorylation genes in liver and skeletal muscle via Akt inhibition of Ppargc1a (20, 35).”
BackgroundInsulin Resistance in the Pathophysiology of Polycystic Ovary Syndrome
Chada, S. R., & Sahay, R. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010014 · Cited by 1
Zheng, Z., Chen, Z., & Zhang, Z. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02864-6 · Cited by 2
“Based on evidence that tumor-infiltrating T cells suppress PGC-1α, a key transcriptional coactivator of mitochondrial biogenesis, one study designed an Akt-insensitive, high-activity variant of PGC-1α (PGC-1α S571A ) [61].”
Loss of cardiomyocyte AKT signaling causes deterioration of lipid metabolism and cellular atrophy
Gödecke, S., Heinen, A., Appel, T., Müller, P., Stemmer, T., Müller, D., Flögel, U., Herebian, D., Solari, F. A., Deenen, R., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156619 · Cited by 1
AKT1 (v-akt murine thymoma viral oncogene homolog 1)
Etro, D., Missiroli, S., Buontempo, F., Neri, L., & Capitani, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44725 · Cited by 2
“In hepatocytes, AKT c an also inhibit gluconeogenesis and fatty acid oxidati on through direct phosphorylation on serine 570 of PGC 1alpha (Li et al., 2007), which is a gene coactivat or with FoxO1 and other transcription factors.”
BackgroundMarín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_4 · Cited by 1
Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis
Kang, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100998 · Cited by 1
Signal transductions and nonalcoholic fatty liver
Sebastian, M. (2024) · International Journal of Clinical Medical Research · doi:10.61466/ijcmr2060004 · Cited by 1
“32 There were some study results showed that nonalcoholic fatty liver disease rat liver phosphatidylinositol 3-kinase and Akt protein were significantly lower than the normal groups.”
Chen, H.-J., Huang, M. N., Abuduwake, M., Mohammadtursun, N., & Yang, X. (2025) · Food, Nutrition and Health. · doi:10.1007/s44403-025-00034-z · Cited by 2
“Phosphorylated AKT inhibits the activity of FoxO1 and PGC-1α, thereby inhibiting gluco-neogenesis [48].”
PI3K/PTEN signaling in liver diseases
Fort, A., Calo, N., Portius, D., Bourgoin, L., Peyrou, M., & Foti, M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch21 · Cited by 1
Toward a Mechanistic Understanding of Hepatic Insulin Action and Resistance
Cook, J. R. (2014) · doi:10.7916/d8j38r4z · Cited by 1
Carnitine Acetyltransferase and Mitochondrial Acetyl-CoA Buffering in Exercise and Metabolic Disease
Hogan, S. S. (2013) · DukeSpace (Duke University) · Cited by 1
Functional analysis of hepatic FOXO3 signalling in glucose and lipid metabolism
Gul, S. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3289 · Cited by 2
Egan, B. (2008) · Dublin City University Open Access Institutional Repository (Dublin City University)
Ribosomal Protein S6 and S6 Kinases
Pende, M., & Treins, C. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_16
Yang, R. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch5 · Cited by 1
Molecular mechanisms of insulin resistance in chronic liver disease
Bernsmeier, C. (2008) · edoc (University of Basel) · doi:10.5451/unibas-004634719
Dubuquoy, C. (2012) · theses.fr (ABES) · doi:10.70675/c6364335z5556z453cz8cb2z5c28558d79b6 · Cited by 1
Impacte Metabòlic de l'Activació de la Glicogen Sintasa Hepàtica
R�os, S. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Ness, G. C., & Edelman, J. L. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.410a3001
“Since PGC-1 transfection acted to inhibit HMGR transcription, we tested the effect PGC-1 siRNA.”
BackgroundInfluentialPham, M. N. (2014) · UA Campus Repository (The University of Arizona)
On the importance of fat cell size, location and signaling in insulin resistance
Franck, N. (2009) · DiVA (Linkoping University)
Tissue Specific Functions and Regulation of DAF-18/PTEN
Chamberlain, G. (2015) · QSpace (Queen's University Library)
Vu, B. G., Schlievert, P. M., Squier, C. A., Yahr, T. L., Horswill, A. R., & Apicella, M. A. (2014) · doi:10.17077/etd.y6n7p4ee
Ann, E., Kang, H., 하창덕, 최규환, & 조진경 (2012) · Exercise Science · doi:10.15857/ksep.2012.21.4.417
Transcriptional Regulation of Mitochondrial Biogenesis and Quality Control
Suliman, H. B., & Piantadosi, C. A. (2015) · Oxidative stress and disease · doi:10.1201/b19420-6
Pirinen, E. (2009) · UEF eRepo (University of Eastern Finland)
Rôle de la Reptine in vivo dans la physiopathologie hépatique
Javary, J. (2017) · theses.fr (ABES) · doi:10.70675/ebb45a18zbd27z4440zaadbz3fd1af023ba5
Molecular Regulation of Gluconeogenesis by the Nuclear Receptors GR and LXRβ
Patel, R. (2015) · TSpace (University of Toronto)
Environmental and gene therapy approaches to improve glycemic control and promote healthy aging
McMurphy, T. B. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Microbial modulation of metabolic diseases
Molinaro, A. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Xu, E. (2012) · Corpus Université Laval (Université Laval)
Jolin-Rodrigue, G. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-23150
Analyse bioénergétique et moléculaire de la physiopathologie du Syndrome de Costello
Dard, L. (2018) · theses.fr (ABES) · doi:10.70675/530b3b78zb34fz482ez95a1z2d2aa0790ad6
Papel de AnxA6 en la regulación del transportador de L-alanina, SNAT4, en hígado de ratón
Blanco‐Muñoz, P. (2020) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Coordinate control of metabolic flux with liver energy status by AMPK in vivo
Hasenour, C. M. (2014)
NK cell-mediated immunotherapy: The exquisite role of PGC-1a in metabolic reprogramming
Gerbec, Z. J., & Malarkannan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00006-0
Díaz, E. (2005) · Acontecimiento: órgano de expresión del Instituto Emmanuel Mounier
Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis
Hua, B., Slarve, I., Datta, A. A., Xu, C., Chen, C., & Stiles, B. L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109089
Chomsy, I. N., Rohman, M. S., Khotimah, H., Widodo, N., & Nugrahini, N. I. P. (2023) · Advances in economics, business and management research/Advances in Economics, Business and Management Research · doi:10.2991/978-94-6463-140-1_48
Multimodal sensing polymer transistors for cell and micro-organ monitoring
Marquez, A. V. (2018) · theses.fr (ABES) · doi:10.70675/a298e628zf30bz4aafz82c5z2e968101999b
Liboz, A. (2022) · theses.fr (ABES) · doi:10.70675/9abd3277zd4c4z48f5za637z73aeb8a7a807 · Cited by 1
Fu-Fang-Qi-Di-Hua-Yu-Tang Improves Diabetic Macrovascular Disease via PI3K/AKT Pathway Regulation
Zhang, S., Yan, M., Liang, P., Ye, Z., Liu, J., Huang, H. M., Li, G., & Wu, H. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s515521
“…and peroxisome proliferation-activated receptor-coactivator 1α (PGC 1α) regulate gene expression and increase glucose production and fatty acid oxidation; 28 they also induce the expression of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene, thereby increasing glucose production.”
Kong, C., Wang, M., Ma, Y., Guo, Z., Yang, Z., & Tang, Q. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042774
Bmi1 deficiency exacerbates hyperoxia-induced acute lung injury in mice
Hernández‐Cuervo, H., Soundararajan, R., Patil, S. S., Breitzig, M., Alleyn, M. D., Narala, V. R., Lockey, R. F., Galam, L., & Kolliputi, N. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1695456
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624137
Wang, Y., Zhang, J., Chu, X., Wang, M., 辛永宁, & Liu, S. (2022) · Figshare · doi:10.6084/m9.figshare.20080962
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624146
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624143
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624131
Xu, L., Zhou, K., Huang, X., Chen, H., Dong, H., & Chen, Q. (2024) · Figshare · doi:10.6084/m9.figshare.25223451
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624119
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624140
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624128
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624122
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2024) · Figshare · doi:10.6084/m9.figshare.26624125
Yuan, Y., Li, Y., Zhang, J., Gao, X., Chen, C., Yu, Z., & Zhou, Y. (2025) · Forensic Toxicology · doi:10.1007/s11419-025-00754-z
Characterizing the ZC3H14-Dependent Neuroprotective Effect of PDGF Signaling
D'Ercole, J. (2024) · TSpace (University of Toronto)
Mishra, P. (2025) · Mspace (University of Manitoba)
López‐Mejía, I. C. (2011) · theses.fr (ABES) · doi:10.70675/c07b5c77zba4dz4e8az9f16z542c1070dc7a
戸田, 郷. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00073758
Hannou, S. A. (2014) · theses.fr (ABES) · doi:10.70675/aeb857aez253cz4b9azab90zc22738177adc · Cited by 1
Régulation du récepteur nucléaire Farnesoid X Receptor par la voie de biosynthèse des hexosamines
Berrabah, W. (2013) · theses.fr (ABES) · doi:10.70675/6dd3fcb5z1c42z4953zb3b1zbd40a3c7f19f
Contrôle de la masse fonctionnelle des cellules β pancréatiques par les glucocorticoïdes et pgc-1α
Besseiche, A. (2015) · theses.fr (ABES) · doi:10.70675/f16ecd6fza687z4a5fzac34zc26774dc9c3f
Etude de la dysfonction cellulaire et moléculaire du syndrome mitochondrial MELAS.
Geffroy, G. (2017) · theses.fr (ABES) · doi:10.70675/a2ae3815zb7a8z4cbcz9a2dz22dbcd055adb
Implication of GSK3β in Islet Inflammation During Diabetes
Pitasi, C. L. (2017) · theses.fr (ABES) · doi:10.70675/a79a58fczcfadz4c5dzbb43ze5302dbe2305
Kaminski, L. (2018) · theses.fr (ABES) · doi:10.70675/7f6ae88bz4f3cz49d3zafcdz8682254b2be3
Etude des isoformes du gène PGC-1a dans le développement musculaire chez le bovin
Bamba‐Funck, J. (2018) · theses.fr (ABES) · doi:10.70675/ffb388c0z6084z4cf4z83bez9c767829ded2
Sabatier, M. (2021) · theses.fr (ABES) · doi:10.70675/b979658az593fz4730zbe37zbff2ac677eb7
Activation of the RAS/PPARα pathway reduces backfat deposition of Gayal (Bos frontalis)
Yu, Y., Fu, B., Fu, R., Jin, C., CHEN, C. C., An, X., Yang, P., Mao, S., & Leng, J. (2026) · BMC Genomics · doi:10.1186/s12864-026-12939-w
“…activation, Akt is activated and may repress forkhead box protein O1 (FoxO1) transcription factors, which is associated with the expression of uncoupling protein 1 (UCP1) and may correlate with enhanced adipocyte thermogenesis [52–54], reduced lipogenesis, and decreased lipid deposition [55–57].”
Parten, A. L., & Rowe, G. C. (2026) · Physiological Reports · doi:10.14814/phy2.71155
“…(p38 MAPK), a positive regulator of PGC-1 α expression and activity (Zhang et al., 2014), and phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), which promotes eNOS phosphorylation and NO production and regulates cellular glucose and lipid metabolism (Haynes et al., 2000; Li et al., 2007).”
Álvarez-Guardia, D. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The role of gp130 receptor signalling in inflammation and metabolism
Neill, B. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27581208
Metadata
- Authors
- Li, X., Monks, B., Ge, Q., & Birnbaum, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cell Signaling Technology (United States) (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature
- Published
- 2007-06
- Volume
- 447
- Issue
- 7147
- Pages
- 1012-1016
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982810858
- Cited by
- 487
- References
- 29
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 25 · 2023: 19 · 2022: 16 · 2021: 26 · 2020: 33 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 24 · 2012: 32
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1α, insulin signaling, hepatic metabolism, type 2 diabetes, insulin resistance, gluconeogenesis, fatty acid oxidation, cardiovascular disease
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Chromatin, Diabetes Mellitus, Type 2, Gene Expression Regulation, Glucose, Liver, Phosphorylation, Phosphoserine, Transcription Factors, Trans-Activators, Down-Regulation, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.